Privia Health Group (PRVA) Renews Anthem Deal, Is The Stock Still Undervalued?
Privia Health Group (PRVA) is back in focus after renewing its agreement with Anthem Blue Cross and Blue Shield in Virginia, which keeps Privia Medical Group physicians in-network for Anthem members across the state.
The renewed Anthem agreement lands during a mixed period for Privia Health Group’s stock, with the share price up 6.75% over the past week but down 20.39% over 90 days and the 1-year total shareholder return declining 14.14%. This hints at improving short-term momentum after a tougher stretch for longer-term holders.
Compare this Anthem renewal with other healthcare plays by scanning 33 healthcare AI stocks that are also leaning into tech driven, value based care models.
After the Anthem news and a 6.75% weekly gain, Privia Health Group now sits between recent weakness and a possible reset. Is this a reasonable entry point, or does waiting for a lower price still make more sense?
Most Popular Narrative: 31% Undervalued
On the numbers used in the most followed narrative, Privia Health Group’s fair value of $31.47 sits well above the last close at $21.67. This frames the recent Anthem renewal against a stock that the narrative treats as materially discounted.
Ongoing expansion of Privia Health Group’s national, primary care focused provider network, with 5,644 implemented providers across 25 states and D.C. caring for over 6.1 million patients, creates more capacity to direct patient volumes into its platform and can support future revenue growth as additional markets mature.
See why 7 investors see Privia Health Group as 31% undervalued.
Result: Fair Value of $31.47 (UNDERVALUED)
Still, the Privia Health Group story only holds if concerns about subscale free cash flow and ongoing insider selling do not keep dragging on investor confidence.
Find out about the key risks to this Privia Health Group narrative.
Another View on Privia Health Group’s Valuation
The story changes when you look at simple pricing ratios. Privia Health Group trades on a P/E of 98.3x, while the US Healthcare industry averages 24.5x, its peers are near 25.6x, and the fair ratio is 30.8x. That is a sizable gap. Is the multiple signaling upside conviction, or valuation risk if growth expectations slip?
To see what the numbers indicate about this price in more detail, investors can review our valuation workup via See what the numbers say about this price — find out in our valuation breakdown..
Next Steps
Mixed signals or quiet opportunity, the Privia Health Group setup only really comes into focus when you handle the numbers yourself and pressure test the story. To see why some investors are still optimistic about the upside potential, start with the 4 key rewards.
Looking for more Privia Health Group style ideas?
If you want a broader watchlist beyond Privia Health Group, use the Simply Wall Street Screener to surface fresh opportunities before they hit everyone else's radar.
- Target potential mispricings by scanning 33 high quality undervalued stocks that combine stronger fundamentals with prices that may not fully reflect their underlying metrics.
- Focus on resilience first and search 32 resilient stocks with low risk scores where balance sheets and risk scores aim to prioritise staying power over headline excitement.
- Hunt for early stage potential by reviewing 20 high quality undiscovered gems that have solid underlying numbers but attract far less attention from the broader market.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com